We have recently begun acquiring a new position in Novo Nordisk. Click here for our investment thesis on NVO stock.

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...